Purchase Order 75F40119P10548
Award Date 8/22/19
Potential Completion Date 8/28/24
Potential Value $255K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the provision of a DRAGEN Appliance for HIVE. The total potential value of the contract is $210,454.80, with a completion date of September 21, 2024. Illumina has a history of providing sequencing instruments, consumables, and support services to various federal agencies, including the...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of a DRAGEN Server and associated software licenses. The DRAGEN Appliance, which utilizes field-programmable gate array (FPGA) technology, will provide hardware acceleration for genomics analysis at the FDA. The contract does not have a set-aside designation. The total ceiling value of the contract is $175,492.00, with a period of performance through...
- This federal contract award, valued at $15,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a DRAGEN CS Level 1 License with a throughput of 100,000GB, with a period of performance from July 25, 2024 to July 24, 2025. The contract is a firm fixed price purchase order and does not have a set-aside designation. Illumina has previously received prime federal...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $180,080.00, is for a preventive maintenance agreement on an Illumina Next Generation Sequencer. The contract has a completion date of November 12, 2024 and was awarded on October 24, 2019. Illumina has a history of providing sequencing systems,...
- This is a delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $113,869.74, is for amending prices and adding a list of items, with a completion date of August 10, 2016. The contract is a firm fixed-price delivery order and does not have a set-aside designation. Illumina has previously received prime federal contract awards from...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,000 purchase order to Illumina, Inc. to provide DRAGEN CS LVL 1 LICENSE THROUGHPUT OF 100,000GB under contract number E21C6L5011010032. The one-year contract, which runs from July 2025 through July 2026, calls for Illumina to deliver genomic sequencing software licensing and throughput on a firm fixed price basis, to be billed quarterly in arrears. As the prime...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the supply of reagent kits. The potential value of the contract is $274,636.99. Illumina has previously received prime federal contracts and subcontracts from agencies such as the NIH, CDC, USDA, and VA, providing a range of sequencing systems, reagents, and bioinformatics support. The...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $122,777.01 contract is for the provision of reagent kits and does not have a set-aside designation. Through past federal contracts, Illumina has supplied a range of sequencing instruments, reagents, and bioinformatics products to support genomic research and...
- This federal contract award by the Department of Health and Human Services Food and Drug Administration adds $110,510.96 in funding to an original requisition with Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract is a firm fixed price Delivery Order with no set-aside designation. Illumina has previously provided sequencing systems, consumables, and support services to various government agencies for research and diagnostics. This award likely supports...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at twenty thousand two hundred ninety-eight dollars and ninety-nine cents ($20,298.99) to Illumina, Inc. to provide a one-year license for the DRAGEN CS Level 1 throughput of one hundred thousand gigabytes. The license will be delivered under a thirteen point six month period running from May seventh, two thousand twenty-one through...